期刊
JOURNAL OF THE NEUROLOGICAL SCIENCES
卷 352, 期 1-2, 页码 1-11出版社
ELSEVIER
DOI: 10.1016/j.jns.2015.03.014
关键词
Mesenchymal stem cells; Stroke; Angiogenesis; Inflammation; Neurogenesis; Clinical trial
Stroke is the second main cause of morbidity and mortality worldwide. The rationale for the use of mesenchymal stem cells (MSCs) in stroke is based on the capacity of MSCs to secrete a large variety of bioactive molecules such as growth factors, cytokines and chemokines leading to reduction of inflammation, increased neurogenesis from the germinative niches of central nervous system, increased angiogenesis, effects on astrocytes, oligodendrocytes and axons. This review presents the data derived from experimental studies and the evidence available from clinical trials about the use of MSCs in stroke therapy. (C) 2015 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据